Navigation Links
Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast
Date:8/7/2009

SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- Volcano Corporation (Nadsaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Canaccord Adams 29th Annual Global Growth Conference on Thursday, August 13.

The presentation by Scott Huennekens, president and chief executive officer, will begin at 11:30 a.m., Eastern Daylight Time (8:30 a.m., Pacific Daylight Time).

The presentation will be available through the conference website at http://www.wsw.com/webcast/canaccord/volc/ and via the company's website at www.volcanocorp.com.

Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Currently, more than 4,400 Volcano IVUS and FM systems are installed worldwide, and more than half of Volcano's revenues are derived from outside the United States. Through its wholly-owned subsidiary, Axsun Technologies, Volcano also develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. These products are sold to a variety of customers, including Nokia Siemens Networks, Ericsson, Alcatel-Lucent and HuaWei Technologies. For more information, visit the company's website at http://www.volcanocorp.com.


'/>"/>
SOURCE Volcano Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Volcano Corporation Schedules First Quarter Conference Call, Webcast
2. Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast
3. Volcano Announces Closing of Axsun Technologies Acquisition
4. Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
5. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
6. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
7. Volcano Presentation at Thomas Weisel Conference to Be Webcast
8. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
9. Volcano Announces Acquisition of Novelis, Inc.
10. Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System
11. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... MILPITAS, Calif. , Feb. 17, 2017 /PRNewswire/ ... posters detailing data on its oral peptide drug ... Congress of the European Crohn,s and Colitis ... in Barcelona, Spain from ... The posters detail preclinical data on Protagonist drug ...
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... WARRINGTON, Pa. , Feb. 16, 2017 /PRNewswire/ ... a biotechnology company focusing on developing aerosolized KL4 ... data from a preclinical influenza study showed that ... overall survival in a well-established preclinical animal model. ... to a growing body of evidence that supports ...
Breaking Biology Technology:
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
(Date:1/25/2017)... YORK , Jan. 25, 2017 The ... Access Management (IAM) lifecycle is comprised of a ... for the purpose of maintaining digital identities and ... resources and applications. There are significant number of ... from time to time by optimizing processes and ...
(Date:1/24/2017)... 2017  It sounds simple and harmless—an electronic ... vital signs and alerts parents on their smart ... level drops. But pediatric experts argue that such ... no evidence of medical benefits, especially to healthy ... to parents of healthy babies, promising peace of ...
Breaking Biology News(10 mins):